Rail Vision Granted U.S. Patent for AI-Powered Railway Obstacle Detection System, Revolutionizing Rail Safety
05 sept. 2024 08h25 HE
|
Rail Vision Ltd.
Ra’anana, Israel, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN) (the “Company”), a technology company at the forefront of revolutionizing railway safety and the data-related...
HydroGraph Announces Two Patent Application Filings for its Innovative Graphene Application
04 sept. 2024 07h30 HE
|
Hydrograph Clean Power Inc.
HydroGraph Clean Power Inc. has announced the filing of two new US patent applications for graphene-coated hollow glass microsphere technology.
Aduro Clean Technologies files new patent application to transform waste plastics and renewable oils into high value BTX chemicals
04 sept. 2024 07h00 HE
|
Aduro Clean Technologies Inc.
Aduro announced a new patent filing covering a new technology for transforming renewable oils and certain waste plastics into higher-value BTX chemicals.
Maris-Tech Receives U.S. Patent for Innovative Forward Error Correction Optimization Method
03 sept. 2024 07h45 HE
|
Maris-Tech Ltd.
The patented method reduces overhead data required in the forward error correction process based on specific characteristics of streamed media communication Rehovot, Israel, Sept. 03, 2024 (GLOBE...
Cingulate to Participate in Benzinga All Live Access Event
27 août 2024 16h30 HE
|
Cingulate Inc.
KANSAS CITY, Kan., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease
27 août 2024 07h00 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
Cingulate Issued European Patent for Lead Asset CTx-1301 for the Treatment of ADHD
15 août 2024 07h45 HE
|
Cingulate Inc.
KANSAS CITY, Kan., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Willo Introduces Several New Product Enhancements to its Industry Leading Locking System, the Willo Wedge™
14 août 2024 11h00 HE
|
Willo Products Company
Willo Products Company, LLC announces the launch of the next generation of its revolutionary swinging door locking system platform.
Medsenic reçoit l'intention de délivrer un brevet européen clé de l'OEB, précieux pour le développement thérapeutique du trioxyde d'arsenic dans la sclérose en plaques récurrente-rémittente.
14 août 2024 01h00 HE
|
BioSenic
INFORMATION PRIVILEGIEE Le médicament de Medsenic, le trioxyde d'arsenic, peut maintenant être étudié pour le traitement de la sclérose en plaques par des cycles répétés d'administration par de...
Medsenic receives the intention to grant a key European patent from EPO, valuable for the therapeutic development of arsenic trioxide in relapsing-remitting multiple sclerosis
14 août 2024 01h00 HE
|
BioSenic
INSIDE INFORMATION Medsenic's experimental drug, arsenic trioxide, can now be investigated for the treatment of multiple sclerosis through repeated cycles of administration by multiple routes,...